Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-12-12 22:44 CET (UTC+1h)

Replicate or not? [Design Issues]

posted by Mikkabel - Belgium, 2017-02-16 12:18  - Posting: # 17068
Views: 2,150


I am new as user of the forum (but not as a viewer) and it is my first question, so please be undestanding with me.....;-)

My company plan to perform a 4-arm PK study with two arms for two different doses of the test formulations and two arms for two different batches of the reference treatment.

Even if two different batches of the reference treatment will be used, could you please advice me if I can considered this design as a replicate design?
Furthermore, on a statistical point of view, is it correct to use the within-subject variability of the reference obtained with this design to widen the acceptance criteria for Cmax?

thank you in advance for your response,
have a nice day!

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,555 Posts in 3,758 Threads, 1,089 registered users;
24 users online (1 registered, 23 guests).

Enlightenment is man’s emergence from his self-imposed nonage
for which he himself was responsible.
Nonage is the inability to use one’s own intellect
without the direction of another.    Immanuel Kant

BEBAC Ing. Helmut Schütz